Article
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study.
Lipids in health and disease - 2 Jul 2022
Kjærgaard Kasper Aalbæk, Harborg Sixten, Jensen Henrik Kjærulf, Borgquist Signe
Abstract excerpt
BACKGROUND: Heterozygous familial hypercholesterolemia (HeFH) due to low-density lipoprotein receptor (LDLR) mutations predisposes patients to highly elevated levels of cholesterol, and patients are at increased risk of adverse cardiovascular events and other morbidities. Whether the LDLR mutation and high cholesterol levels affect the risk of cancer remains unknown. The purpose of the present study was to assess...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
